{"id":205314,"name":"ONEONCOLOGY INC.","slug":"oneoncology-inc","state":"TN","country":"United States of America","description":"Advocacy group for community oncology practices","totalSpending":1120000,"filings":25,"yearlySpending":[{"year":2020,"income":90000},{"year":2021,"income":230000},{"year":2022,"income":200000},{"year":2023,"income":200000},{"year":2024,"income":200000},{"year":2025,"income":200000}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"MMM","display":"Medicare/Medicaid"},{"code":"PHA","display":"Pharmacy"}],"firms":["FARRAGUT PARTNERS LLP"],"lobbyists":["JEFF MACKINNON","JEFFERY MORTIER","SARAH WALTER","J WALSH","JODY GALE","EDWARD WHITFIELD","KRISTEN O'NEILL","WILLIAM KRIEGER","KRISTEN BAUTZ","DYLAN MOORE","CONSTANTINE HINGSON"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug discount program. Issues pertaining to sequestration; Issues related to","Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug discount program. Issues pertaining to sequestration; Issues related to","Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug discount program. Issues pertaining to sequestration; Issues related to","Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug discount program. Issues pertaining to sequestration; Issues related to","Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug discount program. Issues pertaining to sequestration; Issues related to"]}